Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Gentag's pathbreaking IP now covers all key areas of wireless diagnostics including diagnostic skin patches, immunoassays and lab-on-a-chip technologies.

Gentag,Inc.
Posted on: 13 Nov 17
Gentag's pathbreaking IP now covers all key areas of wireless diagnostics including diagnostic skin patches, immunoassays and lab-on-a-chip technologies.

PR Newswire

WASHINGTON, Nov. 13, 2017

WASHINGTON, Nov. 13, 2017 /PRNewswire/ -- Gentag, Inc. is pleased to announce the issuance of 30 additional patents in Europe covering wireless lab-on-a-chip (LOC) diagnostic devices.

The company now holds over 100 issued patents covering cell-based consumer and medical diagnostics that are at the apex of personalized medicine, telemedicine and point-of-care testing. These combined technologies allow a range of applications from simple diagnostics (such as a wireless fever detection skin patch) to sophisticated biomarker analyses for precision medicine.

Recent advances in proteomics and artificial intelligence (AI) will scale up the discovery of new biomarkers and monoclonal antibodies that in turn can be used for the creation of low cost advanced diagnostic sensors.

Using the patented Gentag technology, advanced diagnostics can be done on the spot using a single drop of blood or urine on a disposable wireless device.

New protein, biomarker and metabolite patterns can be applied to early disease detection, preventive medicine, immunotherapy and new drug development.

Disposable wireless diagnostic sensors will allow medical professionals and consumers to undertake diagnostics at the point of care in a market expected to hit $96 billion by 2024.

ABOUT THE GENTAG PATENTS

The new patents are issuing under EP 2843848 B1 and complement the already-issued US lab-on-a-chip patent 9,470,699. Gentag's LOC patents cover protein and biomarker quantification, DNA testing and chemical mixing on a small disposable device controlled and read by a cell phone, using NFC or Bluetooth.  The patents are held by Altivera, LLC a Gentag shareholder owned company.

ABOUT GENTAG

Gentag is a visionary company that combines its advanced knowledge in biology, chemistry and microelectronics to convert proteomics into disposable sensors that will revolutionize diagnostics, proactive medicine, nutrition and the everyday lives of consumers worldwide.

 

For licensing or partnership opportunities please contact:


John Peeters

info@gentag.com

1-240-994-2236

 

View original content:http://www.prnewswire.com/news-releases/gentags-pathbreaking-ip-now-covers-all-key-areas-of-wireless-diagnostics-including-diagnostic-skin-patches-immunoassays-and-lab-on-a-chip-technologies-300554016.html

SOURCE Gentag, Inc.

PR Newswire
www.prnewswire.com

Last updated on: 13/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.